EA
VIVO

Emerald Acquisition’s Meridian Bioscience Inc VIVO Stock Holding History

Emerald Acquisition’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$1.53M Sell
79,202
-119,284
-60% -$2.33M ﹤0.01% 1899
2016
Q2 		$3.87M Buy
+198,486
New +$3.89M 0.01% 1486

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Emerald Acquisition's VIVO Position: Q3 2016 in Review

Emerald Acquisition reduced its Meridian Bioscience Inc (VIVO) stake by 60% in Q3 2016, selling an estimated $2.33M and leaving 79,202 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Emerald Acquisition first reported a position in VIVO in Q2 2016 and has held it in 2 quarters since. The position peaked at $3.87M in Q2 2016. 173 funds tracked by Wall St. Rank hold VIVO as of Q3 2016.

  • Emerald Acquisition held 79,202 shares of Meridian Bioscience Inc worth $1.53M as of Q3 2016.
  • Emerald Acquisition sold 119,284 Meridian Bioscience Inc shares in Q3 2016, an estimated $2.33M.
  • Meridian Bioscience Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1899 holding.
  • Emerald Acquisition first reported a position in Meridian Bioscience Inc in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Meridian Bioscience Inc position peaked at $3.87M in Q2 2016.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.